ARCHIVES

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

This article is from The Cancer Letter archive.

Vol. 36 No. 08 | March 5, 2010

Download PDF Visit The Full Archive

Related Articles

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

DCBDC Board Ok’s New Initiative For Training

November 16, 1990